Diplomat Pharmacy, Inc. (DPLO) - Comprehensive Stock Analysis & Investment Research
Deep dive into Diplomat Pharmacy, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Understanding Company Overview
What this section covers: Essential business information about Diplomat Pharmacy, Inc., including sector classification, industry positioning, and organizational structure.
How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.
For Diplomat Pharmacy, Inc.: Diplomat Pharmacy, Inc. operates in the Retail Trade sector, making it an emerging small-cap investment.
Diplomat Pharmacy, Inc. (Stock Symbol: DPLO) is a leading company in the Retail Trade sector , specifically operating within the Drugstore Chains industry.
The organization employs approximately 2335 professionals worldwide and operates under the strategic leadership of CEO Brian T. Griffin.
The company has established itself as an emerging investment opportunity with substantial growth potential.
Understanding Financial Performance
What these metrics mean: Key financial indicators showing Diplomat Pharmacy, Inc.'s revenue scale, profitability, market value, and shareholder returns.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For Diplomat Pharmacy, Inc.: With $5206M in annual revenue and -12.5% net margin, the company demonstrates developing profitability.
Annual Revenue: $5206 million generating a -12.5% net profit margin .
Market Capitalization: $300 million - Classified as a small-cap investment offering high growth potential.
Return on Equity (ROE): -144.9% - Below-average shareholder return efficiency, indicating areas for operational improvement.
Understanding AI Stock Predictions
What these predictions mean: AI-powered forecasts for Diplomat Pharmacy, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.
How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.
For Diplomat Pharmacy, Inc.: Unlock premium access to view detailed AI predictions and price targets.
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Diplomat Pharmacy, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Understanding Market Position
What this analysis covers: Diplomat Pharmacy, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.
How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.
For Diplomat Pharmacy, Inc.: Strong free cash flow generation demonstrates developing operational efficiency.
Diplomat Pharmacy, Inc. strategically competes in the highly dynamic Drugstore Chains marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .
The company demonstrates robust operational efficiency through strong free cash flow generation of $85 million annually, complemented by impressive -74.1% year-over-year cash flow growth.
The company maintains a healthy 5.9% gross margin, indicating strong pricing power and operational efficiency.